- Lobbying
- Lobbying by The Raben Group (On behalf of the Botanical Education Alliance)
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Mark Rodgers | Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir.,Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir., Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce Deputy Dir., Cong. Rel.; Policy Dir., OMP; Dir. Cong. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce. Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir. COng. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce |
J. Daniel Walsh | Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner |
Claudia Valente | Special Asst. to the Comptroller, U.S. DoD |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Drug Enforcement Administration (DEA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Drug Enforcement Administration (DEA)
Type of Issue
Consumer Issues
Registration
Issue(s) they said they’d lobby about: In opposition to DEA's classification of Kratom as a Schedule I controlled substance.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate